|
rs16754
|
|
|
0.040 |
GeneticVariation |
BEFREE |
The single nucleotide polymorphism (SNP) rs16754 of the WT1 gene has been previously described as a possible prognostic marker in normal karyotype acute myeloid leukemia (AML) patients.
|
23070125 |
2012 |
|
rs16754
|
|
|
0.040 |
GeneticVariation |
BEFREE |
In Korean patients with CN-AML, WT1 SNP rs16754 had no significant impact on clinical outcomes and further investigations are needed to define prognostic implication of WT1 SNP rs16754 in CN-AML.
|
22015946 |
2012 |
|
rs16754
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
|
21659357 |
2011 |
|
rs16754
|
|
|
0.040 |
GeneticVariation |
BEFREE |
WT1 SNP rs16754 may be a novel independent favorable-risk marker in CN-AML patients that might improve risk and treatment stratification.
|
20038731 |
2010 |
|
rs1057520018
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Phe354Leu Polymorphism of <i>LKB1</i> Is a Potential Prognostic Factor for Cytogenetically Normal Acute Myeloid Leukemia.
|
28882949 |
2018 |
|
rs536880332
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Phe354Leu Polymorphism of <i>LKB1</i> Is a Potential Prognostic Factor for Cytogenetically Normal Acute Myeloid Leukemia.
|
28882949 |
2018 |
|
rs59912467
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Phe354Leu Polymorphism of <i>LKB1</i> Is a Potential Prognostic Factor for Cytogenetically Normal Acute Myeloid Leukemia.
|
28882949 |
2018 |
|
rs2234593
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The Wilms Tumor-1 (WT1) rs2234593 variant is a prognostic factor in normal karyotype acute myeloid leukemia.
|
26499507 |
2016 |
|
rs200945282
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Cytogenetically normal acute myeloid leukemia with a novel KIT mutation in exon 11 G565V developing a sole trisomy 13 at relapse: a clinical dilemma.
|
24968822 |
2015 |
|
rs1424098571
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We analyzed polymorphisms in genes encoding cytidine deaminase (CDA 79A>C rs2072671 and -451C>T rs532545), 5'-nucleotidase (cN-II 7A>G rs10883841), and deoxycytidine kinase (DCK 3'UTR 948T>C rs4643786) in 205 de novo NK-AML patients.
|
23873772 |
2013 |
|
rs4643786
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We analyzed polymorphisms in genes encoding cytidine deaminase (CDA 79A>C rs2072671 and -451C>T rs532545), 5'-nucleotidase (cN-II 7A>G rs10883841), and deoxycytidine kinase (DCK 3'UTR 948T>C rs4643786) in 205 de novo NK-AML patients.
|
23873772 |
2013 |
|
rs11554137
|
|
|
0.010 |
GeneticVariation |
BEFREE |
IDH1 SNP rs11554137 but not IDH1 R132 mutations are associated with an inferior outcome in CN-AML.
|
20368538 |
2010 |